Galway, Ireland, May 5- AOTI, INC., announced today that Dr. Christian Frye has joined the company as its Global Medical Director and Chief Science Officer.
Christian graduated from the University of Cologne, Germany in 1994 with his Medical Degree and has more than 15 years of experience in the healthcare field. He also holds an MPH degree from the University of Duesseldorf. In his new role, Christian will provide direction on product development/strategy as well as directly oversee all the Topical Wound Oxygen clinical studies and case study programs.
Prior to joining AOTI, Christian held key leadership roles for companies such as the Linde Group, which is an $18B industrial and medical gas conglomerate made up of the former Linde AG, BOC PLC and AGA SA, Ameda GmbH, a subsidiary company of Munich Re, the world’s second largest reinsurance company, and the German Research Center for the Environmental Health.
AOTI Ltd., a privately held company founded on a decade of experience in providing innovative solutions to resolve severe and chronic wounds. With a leading international management team, extensive worldwide infrastructure, innovative patented technology, and and extensive and growing portfolio of clinical evidence around its Topical Wound Oxygen product range, the company is uniquely positioned to revolutionize the treatment of all advanced wound types.
